BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ. Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. J Psychopharmacol 2022;36:258-72. [PMID: 35107059 DOI: 10.1177/02698811211069100] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD. Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress. Psychedelic Medicine 2023. [DOI: 10.1089/psymed.2022.0011] [Reference Citation Analysis]
2 Aday JS, Skiles Z, Eaton N, Fredenburg L, Pleet M, Mantia J, Bradley ER, Fernandes-osterhold G, Woolley JD. Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice. Psychedelic Medicine 2023. [DOI: 10.1089/psymed.2022.0004] [Reference Citation Analysis]
3 Grover C, Monds L, Montebello M. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders. Australas Psychiatry 2023;:10398562231155125. [PMID: 36753675 DOI: 10.1177/10398562231155125] [Reference Citation Analysis]
4 Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF. Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines. Toxics 2023;11. [PMID: 36851023 DOI: 10.3390/toxics11020148] [Reference Citation Analysis]
5 Beckman M, Poulsen S, Doss M, Stenbæk DS. Editorial: The psychotherapeutic framing of psychedelic drug administration. Front Psychol 2023;14:1121234. [PMID: 36760432 DOI: 10.3389/fpsyg.2023.1121234] [Reference Citation Analysis]
6 Kaup KK, Vasser M, Tulver K, Pikamäe J, Aru J. Psychedelic replications in virtual reality and their potential as a therapeutic instrument: An open-label feasibility study. Front Psychiatry 2023;14:1088896. [PMID: 36937731 DOI: 10.3389/fpsyt.2023.1088896] [Reference Citation Analysis]
7 Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG. Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis. Int J Clin Health Psychol 2023;23:100349. [PMID: 36605409 DOI: 10.1016/j.ijchp.2022.100349] [Reference Citation Analysis]
8 Marguilho M, Figueiredo I, Castro-Rodrigues P. A unified model of ketamine's dissociative and psychedelic properties. J Psychopharmacol 2023;37:14-32. [PMID: 36527355 DOI: 10.1177/02698811221140011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G. Psilocybin for Depression: From Credibility to Feasibility, What's Missing? Pharmaceuticals (Basel) 2022;16. [PMID: 36678564 DOI: 10.3390/ph16010068] [Reference Citation Analysis]
10 Desai S, Jain V, Xavier S, Du W. Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users-A National Survey Study. Children (Basel) 2022;9. [PMID: 36553349 DOI: 10.3390/children9121906] [Reference Citation Analysis]
11 Bohn A, Kiggen MHH, Uthaug MV, van Oorsouw KIM, Ramaekers JG, van Schie HT. Altered States of Consciousness During Ceremonial San Pedro Use. The International Journal for the Psychology of Religion 2022. [DOI: 10.1080/10508619.2022.2139502] [Reference Citation Analysis]
12 Isham A, Elf P, Jackson T. Self-transcendent experiences as promoters of ecological wellbeing? Exploration of the evidence and hypotheses to be tested. Front Psychol 2022;13. [DOI: 10.3389/fpsyg.2022.1051478] [Reference Citation Analysis]
13 Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies. Addict Biol 2022;27:e13229. [PMID: 36301215 DOI: 10.1111/adb.13229] [Reference Citation Analysis]
14 Thal SB, Wieberneit M, Sharbanee JM, Skeffington PM, Baker P, Bruno R, Wenge T, Bright SJ. Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy-A systematized review. J Psychopharmacol 2022;36:1191-207. [PMID: 36263882 DOI: 10.1177/02698811221127954] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Kéri S. Trauma and Remembering: From Neuronal Circuits to Molecules. Life 2022;12:1707. [DOI: 10.3390/life12111707] [Reference Citation Analysis]
16 Gobbi G, Inserra A, Greenway KT, Lifshitz M, Kirmayer LJ. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice. Transcult Psychiatry 2022;59:718-24. [PMID: 36263521 DOI: 10.1177/13634615221119388] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. J Psychopharmacol 2022;36:1100-17. [PMID: 36017784 DOI: 10.1177/02698811221116926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Barnett BS, Ziegler K, Doblin R, Carlo AD. Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data. J Psychopharmacol 2022;36:1118-28. [PMID: 35971893 DOI: 10.1177/02698811221117536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lerer L, Varia J. A long trip into the universe: Psychedelics and space travel. Front Space Technol 2022;3. [DOI: 10.3389/frspt.2022.899159] [Reference Citation Analysis]
20 Jones RH. Secular Mysticism. Religions 2022;13:650. [DOI: 10.3390/rel13070650] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Bosch OG, Halm S, Seifritz E. Psychedelics in the treatment of unipolar and bipolar depression. Int J Bipolar Disord 2022;10:18. [PMID: 35788817 DOI: 10.1186/s40345-022-00265-5] [Reference Citation Analysis]
22 Plesa P, Petranker R. Manifest your desires: Psychedelics and the self-help industry. International Journal of Drug Policy 2022;105:103704. [DOI: 10.1016/j.drugpo.2022.103704] [Reference Citation Analysis]
23 Mccartney AM, Mcgovern HT, De Foe A. Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions. JPS 2022. [DOI: 10.1556/2054.2022.00211] [Reference Citation Analysis]
24 Basedow LA, Kuitunen‐paul S. Motives for the use of serotonergic psychedelics: A systematic review. Drug and Alcohol Review. [DOI: 10.1111/dar.13480] [Reference Citation Analysis]
25 Cole-turner R. Psychedelic Mystical Experience: A New Agenda for Theology. Religions 2022;13:385. [DOI: 10.3390/rel13050385] [Reference Citation Analysis]
26 Zafar R, Sulak D, Brambila J, Nutt D, Schlag A. Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer. Drug Science, Policy and Law 2022;8:205032452211143. [DOI: 10.1177/20503245221114323] [Reference Citation Analysis]